The nano-based theranostics for respiratory complications of COVID-19.
Drug Dev Ind Pharm. 2021 Sep;47(9):1353-1361. doi: 10.1080/03639045.2021.1994989. Epub 2021 Oct 29.
Drug Dev Ind Pharm. 2021.
PMID: 34666567
Review.